RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
TRANSPLANTATION AND CELLULAR THERAPY
Collezione AOU Città della Salute di Torino

Items : 12

Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation. in Transplantation and cellular therapy / Transplant Cell Ther. 2025 Jan;31(1):26.e1-26.e13. doi: 10.1016/j.jtct.2024.10.015. Epub 2024 Nov 4.

2025
AOU Alessandria
AOU Città della Salute di Torino

Fanin R; Patriarca F; Selleri C; Tozzi M; Carnevale F; Boncompagni R; Antonioli E; Oldani E; Degrandi E; Isola M; De Martino M; Chiusolo P; Martino M; Galieni P; Rivela P; Bernasconi P; Parma M; Carluccio P; Mangiacavalli S; Mordini N; Benedetti E; Russo D; Stanghellini MTL; Rambaldi A; Giaccone L; Pucillo M; Nozzoli C;

Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study. in Transplantation and cellular therapy / Transplant Cell Ther. 2025 Apr;31(4):240.e1-240.e9. doi: 10.1016/j.jtct.2025.01.888. Epub 2025 Jan 2

2025
AOU Città della Salute di Torino

Stella F; Pennisi M; Chiappella A; Casadei B; Bramanti S; Ljevar S; Chiusolo P; Rocco AD; Tisi MC; Angelillo P; Cutini I; Martino M; Barone A; Bonifazi F; Santoro A; Sorà F; Novo M; Barbui AM; Russo D; Musso M; Grillo G; Krampera M; Olivieri J; Brunello L; Cavallo F; Massaia M; Arcaini L; Farina L; Zinzani P; et alii...

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial. in Transplantation and cellular therapy / Transplant Cell Ther. 2024 May;30(5):530.e1-530.e8. doi: 10.1016/j.jtct.2024.03.002. Epub 2024 Mar 7

2024
AOU Città della Salute di Torino

Pagliara D; Leardini D; Lo Nigro L; Mura RM; Parasole R; Rabusin M; Cesaro S; Luksch R; Porta F; Casazza G; Zecca M; Favre C; Rondelli R; Calore E; Faraci M; Biffi A; Saglio F; Prete A; Lanino E; Locatelli F; Fagioli F;

Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study. in Transplantation and cellular therapy / Transplant Cell Ther. 2024 Apr;30(4):433.e1-433.e10. doi: 10.1016/j.jtct.2023.12.671. Epub 2024 Jan

2024
AOU Città della Salute di Torino

Locatelli F; Calore E; Faraci M; Tambaro FP; Prete A; Cattoni A; Balduzzi A; Zecca M; Saglio F; Pagliara D; Fagioli F;

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug

2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 May;28(5):258.e1-258.e8. doi: 10.1016/j.jtct.2022.01.026. Epub 2022 Feb 4

2022
AOU Città della Salute di Torino

Gahrton G; García-Cadenas I; Reguera JL; López-Corral L; Nahi H; Granell M; Einsele H; Bruno B; Fanin R; Herrera P; Patriarca F; Reinoso-Segura M; Caballero-Velázquez T; Pérez-Simón JA;

Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Mar;28(3):169.e1-169.e9. doi: 10.1016/j.jtct.2021.12.014. Epub 2021 Dec 2

2022
AOU Città della Salute di Torino

Santoro A; Bruno B; Bramanti S; Mineri R; Tordato F; Valli V; Mannina D; Harbi S; Sarina B; Giaccone L; Faraci D; Maisano V; De Philippis C; Granata A; Richiardi L; Giordano L; Magri F; Furst S; Legrand F; Mariotti J; Devillier R; Blaise D; Castagna L;

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Jun;28(6):284-293. doi: 10.1016/j.jtct.2022.03.019. Epub 2022 Mar 17.

2022
AOU Città della Salute di Torino

Silberman R; Iftikhar R; Abonour R; Moreau P; Otero PR; Malhotra P; Biran N; Callander N; Janakiram M; Mohty M; Prince M; Beksac M; Chaudhry M; Aljurf M; Costa L; Hou J; Schriber J; Quach H; Einsele H; Cook G; Gay F; Costello C; Poudyal BS; Cowan A; Garfall A; Lonial S; Kumar A; Shah N; Kansagra A; et alii...

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ?60 Years from 2000 to 2017: Improvements and Criticisms. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Feb;28(2):96.e1-96.e11. doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bonifazi F; Mammoliti S; Oldani E; Ciceri F; Russo D; Selleri C; Sacchi N; Borghero C; Proia A; Skert C; Carluccio P; Pavone V; Iori AP; Falcioni S; Luppi M; Mazza P; Bassi S; Onida F; Vacca A; Nozzoli C; Casini M; Carella AM; Terruzzi E; Olivieri A; Chiusolo P; De Gobbi M; Natale A; Bramanti S; Bernasconi P; et alii...

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 Oct;27(10):807-816. doi: 10.1016/j.jtct.2021.05.027. Epub 2021 Jun 6.

2021
AOU Città della Salute di Torino

Paiva B; Dwyer MO; Merz M; Melenhorst JJ; Maus MV; Kaiser M; Hillengass J; Gormley N; Ghobrial IM; Gay F; Foureau D; Brownstein C; Demolis P; Bhutani M; Bolli N; Bergsagel PL; Bahlis N; Holstein SA; Pasquini MC; Shah N; Wong SW; Usmani SZ; McCarthy PL;

Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 May;27(5):406.e1-406.e11. doi: 10.1016/j.jtct.2020.11.021. Epub 2021 Feb

2021
AOU Città della Salute di Torino

Gallina AM; Patriarca F; Andreani M; Celeghini I; Carluccio P; Martino M; Olivieri A; Carella AM; Luppi M; Lamparelli T; Milone G; Papalinetti G; La Rocca U; Borghero C; Zallio F; Chiusolo P; Saporiti G; Guidi S; Fagioli F; Farina L; Russo D; Pioltelli P; Benedetti F; Bernasconi P; Arcese W; Vago L; Cerno M; Bruno B; Sessa M; et alii...

Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 Feb;27(2):182.e1-182.e8. doi: 10.1016/j.jtct.2020.10.020. Epub 2020 Dec 1

2021
AOU Città della Salute di Torino

Bruno B; Lanfranco F; Arvat E; Ghigo E; Giaccone L; Cattel F; Motta G; Dionisi-Vici M; Busca A; Scaldaferri M; Dellacasa C; Faraci D; Felicetti F; Zavattaro M; Brignardello E;